Previous 10 | Next 10 |
Trinity Biotech ([[TRIB]] -6.2%) reports Q1 revenue of $25.6M (+20.9% Y/Y), beating expectations by $1.6M.Clinical laboratory revenues increased to $23.7M, which represents an increase of 32.9% compared to Q1, 2020; the rise in revenue was primarily due to strong sale...
Trinity Biotech (TRIB): Q1 GAAP EPS of $0.10 beats by $0.04.Revenue of $25.6M (+20.9% Y/Y) beats by $1.6M.Shares +0.81% PM.Press Release For further details see: Trinity Biotech EPS beats by $0.04, beats on revenue
DUBLIN, Ireland, May 25, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2021. Quarter 1 Results ...
DUBLIN, Ireland, May 19, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2021 on Tuesday, May 25, 2...
Penny Stocks Are Popular Right Now, Here Are 5 to Watch If your goal is to make quick returns in the stock market, penny stocks may be the right investment for you. While long-term investing with penny stocks is possible, short-term or swing trading is much more common. Nevertheless...
Gainers: MultiPlan (MPLN) +17%, Trinity Biotech (TRIB) +15%, Acutus Medical (AFIB) +11%, Novan (NOVN) +8%, Salarius Pharmaceuticals (SLRX) +7%.Losers: Evoke Pharma (EVOK) -17%, Curis (CRIS) -16%, UroGen Pharma (URGN) -16%, Eargo (EAR...
Trinity Biotech ([[TRIB]] -1.5%) has submitted its new HIV screening product, TrinScreen HIV, to the World Health Organisation ((WHO)) for approval.It is expected that the WHO will take a number of months to consider the submission, the company said.The company intends to use that time to pre...
DUBLIN, Ireland, March 30, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has submitted its new HIV screening product, TrinScreen™ HIV, to the World Health Organisation (WHO) for approval. This product, once approved, will allow the Company to build on its strong p...
Penny Stocks You Can Buy For Less Than That Fast-Food Meal; But Are They Worth The Risk? Penny stocks are some of the most popular types of stocks in the market right now. The fact that you can buy hundreds, thousands, or even millions of shares for a few hundred dollars is a big attrac...
Gainers: Humanigen (HGEN) +81%.Universe Pharmaceuticals (UPC) +70%.SeaChange International (SEAC) +60%.Elite Education Group International (EEIQ) +34%.Cyanotech (CYAN) +34%.Fly Leasing (FLY) +27%.Trinity Biotech (TRIB) +25%.Virpax Pharmaceuticals (VRPX) +21%.Hall of Fame Resort & Ent...
News, Short Squeeze, Breakout and More Instantly...
DUBLIN, July 09, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announces the appointment of Louise Tallon as Chief Financial Officer (“...
DUBLIN, June 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced steps to advance its next generation continuous glucose monitoring (...
DUBLIN, June 10, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, announces that its senior management team plans to at...